骨髓瘤管理方面的进展:最新情况
Teresa Meenaghan1, Amjad Hayat2, Geraldine Walpole3
1Advanced Nurse Practitioner, Haematology Department, Galway University Hospital, Ireland.
概括
护士需要更新关于新型骨髓瘤治疗及其副作用的知识. 通过先进的从业人员进行有效的管理,可以改善患者的生活质量和治疗坚持.
科学领域:
- 血液学 血液学 血液学
- 瘤科 护理 护理专业
- 药理学 药理学是指药理学的学科.
背景情况:
- 多发性骨髓瘤是一种具有攻击性的B细胞恶性瘤,其特征是骨髓中不受控制的血细胞增殖.
- 许多新型药物和组合疗法已被批准用于骨髓瘤治疗,这给医疗保健提供者带来了新的挑战.
- 治疗相关副作用的有效管理对于维持患者的生活质量和治疗连续性至关重要.
研究的目的:
- 为提供针对多发性骨髓瘤最近批准的药物的概述.
- 为了突出与这些新型骨髓瘤治疗相关的显著副作用.
- 强调护士,特别是临床护士专家和高级护士从业人员在管理这些副作用方面的关键作用.
主要方法:
- 对多发性骨髓瘤最近批准的药物的文献综述.
- 从临床试验和营销后监测中报告的副作用的综合.
- 讨论护理对副作用识别和管理的影响.
主要成果:
- 几种新的药物和药物组合已被批准用于多发性骨髓瘤治疗.
- 这些较新的药物与一系列新的和重要的副作用有关,需要专门的护理知识.
- 高级实践护士在患者教育,副作用监测和支持性护理方面发挥着关键作用.
结论:
- 对于护士来说,对新出现的骨髓瘤治疗及其不良事件的持续教育至关重要.
- 通过高级实践护士主动和熟练地管理副作用,可以优化患者的治疗结果.
- 支持患者和家人管理副作用是延长治疗和保持良好生活质量的关键.
更多相关视频
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.9K
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
8.7K
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Tumor Immunotherapy
551
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Bone Marrow Sampling and Transplants
352
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
352
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
